相关实验视频

Updated: Jul 12, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

设计,合成,抗癌评估,和分子对接研究的Oxazole-Incorporated纳菲里丁衍生物

Singamsetty Rangaswamy¹, Reddymasu Sreenivasulu², Vankayala Ramesh Babu¹

¹Department of Chemistry, GITAM School of Science, Gandhi Institute of Technology and Management (Deemed to be University), Visakhapatnam, Andhra Pradesh, 530045, India.

Chemistry & biodiversity

|October 21, 2023

概括

新型的牛醇-纳菲胺衍生物对乳腺癌,肺癌和前列腺癌细胞系表现出强大的抗癌活性. 最有效的化合物显示出显著的疗效,通过分子对接模拟验证.

科学领域:

药用化学医学化学
有机合成有机合成
癌症研究癌症研究

背景情况:

癌症仍然是全球主要的死亡原因,需要开发新的治疗药物.
纳菲西里丁和牛醇支架因其多样化的生物活性而闻名,包括抗癌性质.

研究的目的:

设计,合成和评估新型含氧沙纳二衍生物的抗癌潜力.
识别具有针对各种人类癌症细胞系的显著活性的化合物.

主要方法:

合成了一系列21种牛醇-纳菲胺衍生物 (21a-j).
使用MTT测定对人类乳腺 (MCF-7),肺 (A549) 和前列腺 (PC3 & DU-145) 癌细胞系进行抗癌活性查.
分子对接模拟用于预测结合相互作用和验证实验结果.

主要成果:

一种衍生物N-(6-chloro-3-(4-(3,4,5-trimethoxyphenyl) oxazol-2-yl) -1,5-naphthyridin-4-yl) oxazol-2-amine在所有具有低IC50值的测试细胞系中表现出强烈的抗癌活性.
其他几种衍生品也显示出有前途的抗癌作用.
分子对接研究支持观察到的活动,表明有利的相互作用能量.

结论:

合成的牛醇-纳菲胺衍生物代表了一类有前途的抗癌药物.
这种化合物需要进一步研究其在癌症治疗中的治疗潜力.
结构修改,特别是三甲基替代剂,显著提高了抗癌疗效.

关键词:

它具有抗癌活性,具有抗癌活性.子[b][1,5]纳夫二氨酸这里是etoposide的位置.在thomycin C中使用.纳夫提里丁 (NAPHTHYRIDINE) 是一种含有甲的化合物.

更多相关视频

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...